Publication : Cancer

Cancer Publication Links

 

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Larkin J, et al., “Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.,” N. Engl. J. Med., vol. 373, no. 1, pp. 23–34, Jul. 2015.
View Paper

 

B cells and Antibody Production in Melanoma

Da Gama Duarte, Jessica, Janique M. Peyper, and Jonathan M. Blackburn. 2018. “B Cells and Antibody Production in Melanoma.” Mammalian Genome. http://link.springer.com/10.1007/s00335-018-9778-z
View Paper

 

A Diagnostic Autoantibody Signature for Primary Cutaneous Melanoma

Zaenker, Pauline et al. 2018. “A Diagnostic Autoantibody Signature for Primary Cutaneous Melanoma.” Oncotarget 9(55): 30539–51. http://www.ncbi.nlm.nih.gov/pubmed/30093967
View Paper

 

Novel Potential Serological Prostate Cancer Biomarkers Using CT100+ Cancer Antigen Microarray Platform in a Multi-Cultural South African Cohort

Adeola, Henry A et al. 2016. “Novel Potential Serological Prostate Cancer Biomarkers Using CT100+ Cancer Antigen Microarray Platform in a Multi-Cultural South African Cohort.” Oncotarget 7(12): 13945–64. http://view.ncbi.nlm.nih.gov/pubmed/26885621
View Paper

 

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma

Da Gama Duarte, Jessica et al. 2018. “Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin Followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.” Frontiers in Immunology 9. http://journal.frontiersin.org/article/10.3389/fimmu.2018.00411/full
View Paper

 

Protein Function Microarrays: Design, Use and Bioinformatic Analysis in Cancer Biomarker Discovery and Quantitation

Duarte, Jessica, Jean-Michel Serufuri, Nicola Mulder, and Jonathan Blackburn. 2013. “Protein Function Microarrays: Design, Use and Bioinformatic Analysis in Cancer Biomarker Discovery and Quantitation.” In , 39–74. http://link.springer.com/10.1007/978-94-007-5811-7_3
View Paper

 

Functional Protein Microarrays for Parallel Characterisation of P53 Mutants

Boutell, Jonathan M. et al. 2004. “Functional Protein Microarrays for Parallel Characterisation of P53 Mutants.” PROTEOMICS 4(7): 1950–58. http://doi.wiley.com/10.1002/pmic.200300722.
View Paper

 

Development Of A Novel, Quantitative Protein Microarray Platform for the Multiplexed Serological Analysis of Autoantibodies to Cancer-Testis Antigens

Beeton-Kempen, Natasha et al. 2014. “Development of a Novel, Quantitative Protein Microarray Platform for the Multiplexed Serological Analysis of Autoantibodies to Cancer-Testis Antigens.” International journal of cancer 135(8): 1842–51. http://www.ncbi.nlm.nih.gov/pubmed/24604332
View Paper

 

Serologic Autoantibodies as Diagnostic Cancer Biomarkers — A Review

Zaenker, P., and M. R. Ziman. 2013. “Serologic Autoantibodies as Diagnostic Cancer Biomarkers–A Review.” Cancer Epidemiology Biomarkers & Prevention 22(12): 2161–81. http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-13-0621
View Paper

 

Seromic Analysis of Antibody Responses in Non-Small Cell Lung Cancer Patients and Healthy Donors Using Conformational Protein Arrays

Gnjatic, Sacha et al. 2009. “Seromic Analysis of Antibody Responses in Non-Small Cell Lung Cancer Patients and Healthy Donors Using Conformational Protein Arrays.” Journal of Immunological Methods 341(1–2): 50–58. http://linkinghub.elsevier.com/retrieve/pii/S0022175908003244
View Paper

Publication : Autoimmune Disease

Cancer Publication Links

 

Applications of Functional Protein Arrays for Detection
and Development of Autoantibody-based Diagnostics
and Therapeutics

Jonathan Blackburn and Farhanah Aziz
View Paper

 

Autoantibodies Targeting TLR and SMAD Pathways Define New Subgroups in Systemic Lupus Erythematosus

Lewis, Myles J. et al. 2018. “Autoantibodies Targeting TLR and SMAD Pathways Define New Subgroups in Systemic Lupus Erythematosus.” Journal of Autoimmunity 91: 1–12. https://linkinghub.elsevier.com/retrieve/pii/S0896841118300234
View Paper

Publication : Neurodegenerative Disease

Cancer Publication Links

 

Augmentation of Autoantibodies by Helicobacter pylori in Parkinson’s Disease Patients May Be Linked to Greater Severity

Suwarnalata, Gunasekaran et al. 2016. “Augmentation of Autoantibodies by Helicobacter pylori in Parkinson’s Disease Patients May Be Linked to Greater Severity.” PloS one 11(4). http://view.ncbi.nlm.nih.gov/pubmed/27100827
View Paper

Publication : Infectious Disease

Cancer Publication Links

 

Autoantibody Profile of Patients Infected with Knowlesi Malaria

Liew, Jonathan et al. 2015. “Autoantibody Profile of Patients Infected with Knowlesi Malaria.” Clinica chimica acta; international journal of clinical chemistry 448: 33–38. http://view.ncbi.nlm.nih.gov/pubmed/26086445
View Paper

 

Identifying Protein Biomarkers in Predicting Disease Severity of Dengue Virus Infection Using Immune-Related Protein Microarray

Soe, Hui Jen et al. 2018. “Identifying Protein Biomarkers in Predicting Disease Severity of Dengue Virus Infection Using Immune-Related Protein Microarray.” Medicine 97(5): e9713. http://insights.ovid.com/crossref?an=00005792-201802020-00013
View Paper

Publication : Technology

Cancer Publication Links

 

Protein Function Microarrays for Customised Systems-Oriented Proteome Analysis

Blackburn, Jonathan M, and Aubrey Shoko. 2011. “Protein Function Microarrays for Customised Systems-Oriented Proteome Analysis.” Methods in molecular biology (Clifton, N.J.) 785: 305–30. http://www.ncbi.nlm.nih.gov/pubmed/21901609
View Paper

 

Advances in the Development of Human Protein Microarrays

Duarte, Jessica G., and Jonathan M. Blackburn. 2017. “Advances in the Development of Human Protein Microarrays.” Expert Review of Proteomics 14(7): 627–41. https://www.tandfonline.com/doi/full/10.1080/14789450.2017.1347042.
View Paper

X